Spero Therapeutics (SPRO) Other financing activities (2017 - 2021)
Spero Therapeutics (SPRO) reported Other financing activities of -$163000.0 for Q4 2021, down 143.7% on a YoY basis from $373000.0 in Q4 2020, and down 263.0% quarter-over-quarter from $100000.0 in Q3 2021.
Spero Therapeutics (SPRO) Other financing activities (2017 - 2021) Analysis & Trends
Spero Therapeutics has reported Other financing activities for 5 years, with the latest figure at -$163000.0 in Q4 2021.
- For the quarter ending Q4 2021, Other financing activities fell 143.7% year-over-year to -$163000.0; the trailing twelve-month figure through Dec 2022 stood at -$63000.0 (down 175.9% YoY), and the FY2021 full-year result was $248000.0, down 73.98% from the prior year.
- Other financing activities for Q4 2021 stood at -$163000.0, down from $100000.0 in the prior quarter.
- The five-year high for Other financing activities was $3.1 million in Q4 2017, with the low at -$753000.0 in Q2 2018.
- Historically, Other financing activities has averaged $287411.8 across 5 years, with a median of $109000.0 in 2021.
- Annual changes were most pronounced in 2018 — Other financing activities plunged 1830.77% — and 2020, when it soared 2100.0%.
- Spero Therapeutics' Other financing activities stood at $3.1 million in 2017, then plunged by 75.58% to $749000.0 in 2018, then plunged by 89.45% to $79000.0 in 2019, then jumped by 372.15% to $373000.0 in 2020, then slumped by 143.7% to -$163000.0 in 2021.
- The last three Other financing activities figures came in at -$163000.0 (Q4 2021), $100000.0 (Q3 2021), and $109000.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -163,000.00 |
| Dec 31, 2021 | -163,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 109,000.00 |
| Mar 31, 2021 | 37,000.00 |
| Mar 31, 2021 | 37,000.00 |
| Dec 31, 2020 | 373,000.00 |
| Dec 31, 2020 | 373,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 150,000.00 |
| Jun 30, 2020 | 150,000.00 |
| Mar 31, 2020 | 352,000.00 |
| Mar 31, 2020 | 352,000.00 |
| Sep 30, 2019 | 79,000.00 |
| Sep 30, 2019 | 79,000.00 |
| Jun 30, 2019 | 63,000.00 |
| Jun 30, 2019 | 63,000.00 |